• Home
  • Articles
  • Prepare ALS-Con-201 Question Answers - ALS-Con-201 Exam Dumps [Q32-Q56]

Prepare ALS-Con-201 Question Answers - ALS-Con-201 Exam Dumps [Q32-Q56]

Share

Prepare ALS-Con-201 Question Answers - ALS-Con-201 Exam Dumps

Real Salesforce ALS-Con-201 Exam Questions [Updated 2026]

NEW QUESTION # 32
Choose 1 option.
Cumulus Pharma is preparing for the commercial launch of a new product, "Immunexis." The sales operations director wants to implement a strategic sampling control that is not required by law, but is critical for inventory management. The requirements for this rule are:
Period Logic: The limit period must dynamically begin on the Product Launch Date rather than the standard Calendar Year.
Enforcement: To avoid blocking sales momentum, the system must only display a warning, or soft limit, if a rep exceeds the allocated quantity, allowing the rep to proceed with the disbursement if necessary.
Which Sample Limit Template type meets these requirements?

  • A. Generic
  • B. Country
  • C. Advanced

Answer: C

Explanation:
Option C is correct because Advanced Sample Limit Templates are designed for custom, complex sample-limit rules. Salesforce Help explains that advanced sample limit templates are used to define custom sample limit rules for more complex needs and stricter requirements. This scenario requires two non-basic behaviors: a dynamic period start based on the product launch date and soft-limit enforcement that warns the rep but still allows the disbursement to proceed. Those requirements go beyond a generic calendar-year rule.
A Generic Sample Limit Template is not the best answer because generic templates are better suited for standard sample-limit logic. The requirement explicitly says the limit period must begin on the Product Launch Date rather than the standard Calendar Year, which makes the rule more specialized. A Country Sample Limit Template is also not correct because country templates are used for country-specific legal or regulatory sampling limits. In this question, the control is strategic and inventory-driven, not a legal requirement tied to a specific country.
Advanced templates are the correct fit because they allow more flexible configuration for business-specific sample controls, including nonstandard periods and warning-based enforcement. Therefore, the consultant should use an Advanced Sample Limit Template for the Immunexis launch sampling rule.
=========


NEW QUESTION # 33
Choose 1 option.
Cumulus Pharma wants to roll out Tableau Next to provide its field sales team with real-time performance insights, such as "Visit Plan Attainment," directly within the Agentforce Life Sciences mobile app. The relevant Metrics have been created, the Tableau View component has been added to the Mobile Home Page Lightning record page, and the metadata cache has been refreshed. However, when a field sales rep logs in to the app, the Metrics component displays an error indicating insufficient privileges and the metrics do not load.
Which Tableau Next permission set should the Agentforce Life Sciences Consultant assign to resolve this issue?

  • A. CRM Analytics Plus User
  • B. Tableau Next Creator
  • C. Tableau Next Consumer

Answer: C

Explanation:
The correct answer is C because field sales reps only need to view and consume Tableau Next metrics in the Life Sciences mobile app. Salesforce Help for Tableau Next in Life Sciences Cloud explains that Tableau Next integrates with Life Sciences Cloud to provide actionable insights and enhanced visualizations. Salesforce's Tableau Next permission guidance also identifies Tableau Next Consumer as the permission set used for viewing Tableau Next content and interacting with metrics, while creator-level access is intended for users who create and manage Tableau Next assets.
In this scenario, the technical setup has already been completed: the metrics exist, the Tableau View component has been placed on the Mobile Home Page Lightning record page, and the mobile metadata cache has been refreshed. The remaining issue is an insufficient-privileges error, which indicates that the user lacks the Tableau Next permissions required to load and consume the metric. Assigning Tableau Next Consumer grants the field rep the appropriate access level without giving unnecessary authoring privileges.
Option A, Tableau Next Creator, is incorrect because field sales reps are not creating or administering metrics; they only need to consume them. Option B, CRM Analytics Plus User, is also incorrect because the requirement is specifically for Tableau Next metrics, not legacy CRM Analytics access. Therefore, the consultant should assign the Tableau Next Consumer permission set.
=========


NEW QUESTION # 34
Choose 1 option.
Cumulus Pharma wants to track email interactions and in-person visits as two distinct types of interactions. The system should count these separately to ensure field sales reps meet their target of six emails and three visits. The solution must use standard Activity Plan configuration objects to categorize these interactions based on the Visit Channel.
Which object defines these distinct interaction categories?

  • A. Provider Activity Plan Interaction
  • B. Provider Activity Goal
  • C. Provider Activity Measure Type

Answer: C

Explanation:
Option A is correct because Provider Activity Measure Type defines how engagement activities are measured and categorized in Activity Plans. Salesforce Help explains that an activity can be an interaction with a healthcare professional, such as a visit, and that a channel is the medium in which the interaction or activity occurs. This is exactly the requirement: Cumulus Pharma wants to distinguish email interactions from in-person visits so each channel can be counted separately against the field rep's targets.
Salesforce Help for creating Activity Plans also states that admins should verify that a provider activity measure type has been created to track provider engagement activities. This confirms that Provider Activity Measure Type is the setup object used to define what kind of activity is being measured.
Option B, Provider Activity Goal, is not correct because it represents the target or goal assigned to providers or reps, such as six emails or three visits. It does not define the activity category itself. Option C, Provider Activity Plan Interaction, is also not the best answer because the question asks which configuration object defines the distinct interaction categories. The measure type is the categorization layer that can use Visit Channel, such as Email or In-Person, to count interactions separately. Therefore, Provider Activity Measure Type is the correct answer.
=========


NEW QUESTION # 35
Choose 1 option.
A field sales rep wants to bring a Medical Science Liaison (MSL) into a scheduled remote visit with a Healthcare Provider (HCP) to answer a complex clinical question. The system must track the MSL's participation in the visit.
Which standard Visit Management action supports this requirement?

  • A. Create a new Visit record for the MSL.
  • B. Send the meeting link to the MSL by email.
  • C. Add Visitors (Users) to a Visit.

Answer: C

Explanation:
The correct answer is C because Salesforce Life Sciences Visit Management supports adding internal users as visitors to a visit. Salesforce Help for Add Internal Users as Visitors states that administrators can configure the visitors feature so field reps can record internal colleagues who participate in visits and automatically share visit data with them. This directly matches the requirement to include an MSL in the scheduled remote visit and track that person's participation.
The MSL is not the primary HCP attendee and does not need a separate visit record. Instead, the MSL is an internal participant supporting the visit. Using the standard Add Visitors (Users) to a Visit action keeps the visit record intact while documenting the MSL as a participating internal user. It also supports better compliance, collaboration, and reporting because the MSL's involvement is recorded against the actual visit.
Option A is incorrect because creating a separate Visit record would fragment the visit history and could cause duplicate or inconsistent reporting. Option B is incomplete because emailing the meeting link may help the MSL join the session, but it does not track the MSL's participation in the Life Sciences Visit Management data model. The correct standard action is Add Visitors (Users) to a Visit.
=========


NEW QUESTION # 36
Choose 1 option.
Cumulus Pharma notices that synchronization transactions have failed, impacting sales users' ability to view recently created records offline in the Agentforce Life Sciences mobile app.
What should an Agentforce Life Sciences Consultant recommend to identify potential synchronization transaction failures?

  • A. Leverage Simulation Mode to test transactions.
  • B. Check Event Monitoring Logs in the Admin Console.
  • C. Enable Send Warning Emails for sales users.

Answer: A

Explanation:
Option C is correct. Salesforce Life Sciences Cloud documentation for Synchronization Management describes Simulation Mode as the feature used to proactively find and fix synchronization problems before they affect users. This is directly aligned with the question's wording: the consultant must identify potential synchronization transaction failures that could prevent recently created records from being available offline in the Life Sciences mobile app. Simulation Mode helps admins validate synchronization behavior in advance, rather than waiting for sales users to encounter missing or failed offline records.
Option B is not the best answer, even though the question included it as the proposed answer. Event Monitoring can be useful for broader Salesforce activity monitoring, but the Salesforce Life Sciences synchronization documentation points specifically to Synchronization Management and Simulation Mode for identifying and resolving sync problems in the Life Sciences mobile app context. Option A is also incorrect because sending warning emails to sales users would notify people after a problem or warning occurs; it does not test synchronization transactions or identify potential failures before users are impacted.
Therefore, to identify potential synchronization transaction failures and reduce offline data issues for field sales users, the consultant should leverage Simulation Mode to test transactions.
=========


NEW QUESTION # 37
Choose 1 option.
Cumulus Pharma wants to use Activity Plans to measure high-impact activities with specific Healthcare Providers (HCPs) who are aligned with the company's objectives and need to be measured differently.
Which Activity Plan configuration on the Provider Activity Goal Measure screen is critical to measure such high-impact activities?

  • A. Select the option Weighted Goal for the Type field.
  • B. Enter the weighted percentage in the Activity Impact field.
  • C. Select the option High Impact Goal for the Type field.

Answer: A

Explanation:
Option B is correct because Salesforce Life Sciences Activity Plans use weighted goals to measure activities differently based on business importance. Salesforce Help for creating Activity Plans states that, to track weighted goals, administrators create Provider Activity Goal Measure records to define weights, select Weighted Goal in the Type field, and assign a value in Activity Weight Value. This directly supports the requirement to measure high-impact activities differently from standard activities.
Activity Plans are designed to transform provider interaction strategies into actionable goals and targets for field representatives. When certain activities with specific HCPs are more strategically important, weighted goals allow those activities to contribute differently to plan performance. This is more precise than simply counting every activity equally.
Option A is incorrect because "High Impact Goal" is not the documented Type value for this configuration. The Salesforce Help wording identifies "Weighted Goal" as the Type value used for weighted measurement. Option C is also not correct because the documented field is Activity Weight Value, not Activity Impact. Even if a percentage-based concept sounds plausible, the standard configuration step is to set the Provider Activity Goal Measure Type to Weighted Goal and enter the weight value. Therefore, the consultant should select Weighted Goal for the Type field.
=========


NEW QUESTION # 38
Choose 1 option.
An Agentforce Life Sciences Consultant at Cumulus Pharma needs to configure Medical Inquiries to ensure a compliant workflow between departments. The requirement states that field sales reps must only be permitted to draft, sign, and submit inquiries, while Medical Science Liaisons (MSLs) must only be permitted to assign and respond to them.
What should the consultant configure on the Medical Inquiry object to enforce these specific user actions?

  • A. Create a custom formula field to define the allowed actions based on the user's role and assigned permissions.
  • B. Create record types for Sales and Medical roles with unique page layouts to restrict available buttons.
  • C. Create a Flow action to dynamically evaluate user credentials during the Inquiry lifecycle.

Answer: B

Explanation:
The correct answer is A from the available options, because the requirement is to control which user actions are exposed to different roles during the Medical Inquiry lifecycle. Salesforce Help for Medical Inquiries states that organizations can define relevant workflow actions for tasks users perform in the medical inquiry process, such as inquiry submission and assignment. Salesforce also describes a compliant role separation where field sales reps can submit medical inquiries, while Medical Science Liaisons can assign and respond to them.
The ideal Salesforce Life Sciences configuration pattern is to use Medical Inquiry workflow actions and workflow paths to control status transitions, actions, and permissions. However, among the provided answer choices, record types with role-specific page layouts is the only option that directly supports restricting the available buttons and actions by user role. This enables sales users to see only draft, sign, and submit actions, while MSL users see only assignment and response actions.
Option B is incorrect because a formula field can calculate or display logic, but it cannot enforce workflow actions or user interaction permissions by itself. Option C is also incorrect because a Flow action could add custom logic, but it is not the standard configuration approach for restricting Medical Inquiry lifecycle actions. Therefore, the best available answer is A.
=========


NEW QUESTION # 39
Choose 1 option.
An Agentforce Life Sciences Consultant is setting up sample limits for a controlled substance. Legal requires that, if a field sales rep attempts to disburse more than the allowed quantity, the system must strictly prevent the transaction. The rep should receive a message and be unable to submit the visit until the quantity is corrected.
How should the consultant configure the Limit Enforcement Type on the Sample Limit Template?

  • A. Set the Limit Enforcement Type to Warning.
  • B. Set the Limit Enforcement Type to Error.
  • C. Set the Limit Enforcement Type to Block.

Answer: B

Explanation:
Option C is correct because the requirement is strict enforcement. Salesforce Help for Sample Limit Template types states that when the enforcement type is Error, distributions are blocked after limits are met. This directly matches the legal requirement in the question: the field sales rep must be prevented from submitting the visit when the disbursement quantity exceeds the allowed limit.
A controlled substance requires a hard compliance stop rather than a soft business warning. Setting the Limit Enforcement Type to Error ensures that the rep receives an error message and must correct the sample quantity before continuing. This protects the company from noncompliant disbursements and supports controlled sampling governance.
Option A is incorrect because Warning is a soft-limit behavior. A warning may alert the rep that the limit has been exceeded, but it allows the rep to proceed. That does not meet the requirement to strictly prevent the transaction. Option B is also not the best answer because "Block" is not the documented Limit Enforcement Type in the sample-limit template options shown in Salesforce's Life Sciences sample limit resources. The documented strict enforcement behavior is Error. Therefore, for controlled substances or any legally required hard stop, the consultant should configure the Sample Limit Template with Limit Enforcement Type set to Error.


NEW QUESTION # 40
Choose 1 option.
Cumulus Pharma implemented a custom predictive model outside of Salesforce to determine the optimal product message for Healthcare Providers (HCPs). The company wants to display these recommendations to its field sales teams within Salesforce.
Which object should an Agentforce Life Sciences Consultant load the external scores and rankings into to use the Next Best Message feature?

  • A. Score Explainability Info
  • B. Territory Account Product Message Score
  • C. Visit Recommendation

Answer: B

Explanation:
The correct answer is A because Next Best Message uses product-message scoring data at the territory-account-product-message level. Salesforce's Life Sciences Cloud Developer Guide states that Next Best Message provides tailored and relevant messages for each product associated with an account. Salesforce also documents the related scoring object and describes the calculation agent used to calculate the territory account product message score based on various metrics.
The scenario says Cumulus Pharma already has a custom predictive model outside Salesforce. The goal is not to build the model inside Salesforce, but to surface the model's results to reps through the standard Next Best Message capability. Therefore, the external scores and rankings should be loaded into the object that stores ranked product-message recommendations for accounts in territories: Territory Account Product Message Score.
Option B, Visit Recommendation, is not the best answer because the requirement is specifically about product messages for HCPs, not general recommendations tied to a visit. Option C, Score Explainability Info, may support interpretation or explanation of scoring, but it is not the primary object used to load the external product-message score and ranking. To use Next Best Message with external model outputs, the consultant should load the results into Territory Account Product Message Score.
=========


NEW QUESTION # 41
Choose 1 option.
Cumulus Pharma wants a medical inquiry process configured where only a designated persona can assign and respond to medical inquiries.
Which configuration supports this compliance requirement?

  • A. Use a custom permission set and enable the Assign and Respond to Inquiries app permission.
  • B. Set up a new custom formula field on the Inquiry object to conditionally display action buttons based on the user's profile.
  • C. Create workflow actions and associate workflow actions with profiles in the Life Sciences Admin Console.

Answer: C

Explanation:
Option B is correct because Salesforce Life Sciences Medical Inquiries uses workflow actions and persona/profile-based configuration to control who can perform specific inquiry actions, such as assigning and responding. Salesforce Help states that, before setting up Medical Inquiry, admins must make sure the required user profiles, licenses, and permission sets are in place. It also describes that medical science liaisons can assign and respond to inquiries, which confirms that these actions are intended to be controlled by role or persona.
Salesforce's Life Sciences workflow documentation also identifies workflow actions and workflow stages as part of the Medical Inquiry management setup. The Medical Inquiries workflow setup includes action buttons, workflow stages, stage operations, and conditions, allowing admins to expose or restrict actions based on configured roles and workflow state.
Option A is not the best answer because the requirement is not simply to grant a broad app permission; it is to ensure that only a designated persona can perform the assign and respond actions in the controlled Medical Inquiry process. Option C is incorrect because a custom formula field only affects display logic and does not enforce the standard workflow-action permission model. Formula-based visibility also creates compliance risk because it can hide buttons without truly governing the underlying operation. Therefore, the consultant should create workflow actions and associate those actions with the appropriate profiles in the Life Sciences Admin Console.
=========


NEW QUESTION # 42
Choose 1 option.
An Agentforce Life Sciences Consultant configured an Activity Plan for the West Coast territory to support a product launch. Field sales reps must submit their proposed visit targets for manager review by a specific date. Any target adjustment exceeding allowed limits must be flagged for review.
How should the consultant configure these deadlines and adjustment limits in Agentforce Life Sciences?

  • A. Global Calculation Settings for the Provider Activity Measure Type
  • B. Goal Definition record assigned to the Territory Business Plan
  • C. Activity Plan record within the Review Details section

Answer: C

Explanation:
The correct answer is B because the deadlines and review windows for activity-plan adjustments are configured on the Activity Plan record, specifically in the review-related configuration. Salesforce Help for creating Activity Plans references fields such as Reviewer Plan Adjustment Start Date and Reviewer Plan Adjustment End Date, which define the date range in which the manager can review adjustment requests.
The scenario describes a plan-level governance requirement: field sales reps must submit proposed visit targets by a specific deadline, and adjustments above allowed thresholds must be reviewed. This belongs to the Activity Plan configuration because the plan defines the cycle, timing, targets, review process, and adjustment behavior for the territory or provider planning period. Configuring the Review Details section ensures that the plan controls when reps can submit changes and when managers can review them.
Option A is incorrect because Global Calculation Settings for a Provider Activity Measure Type would relate to how measures or calculations are evaluated, not the submission and manager-review deadline for a specific Activity Plan. Option C is also incorrect because a Goal Definition represents a reusable planning objective, but it does not control the operational review dates and adjustment thresholds for a specific West Coast Activity Plan. Therefore, the consultant should configure the deadlines and adjustment limits on the Activity Plan record within the Review Details section.
=========


NEW QUESTION # 43
Choose 1 option.
A data analyst wants to query the total interaction target for a Healthcare Provider (HCP) for the current period. The analyst needs to understand the high-level association of an Account to an Activity Plan as the parent record and which child object contains the specific targets.
Which objects represent this association?

  • A. Parent: Provider Activity Goal; Child: Provider Activity Goal Measure
  • B. Parent: Assessment Task; Child: Assessment Indicator
  • C. Parent: Activity Plan; Child: Account Goal

Answer: A

Explanation:
The correct answer is B because the Provider Activity Goal object represents the parent-level association between a provider account and an activity plan, while Provider Activity Goal Measure stores the specific measurable targets associated with that goal. Salesforce's Life Sciences Cloud Developer Guide describes ProviderActivityGoal as storing progress toward the target for an account, including the percentage of the overall goal achieved by completed activities. Salesforce's Life Sciences standard objects also include ProviderActivityGoalMeasure, which represents the activity goal measure details.
In practical reporting and querying terms, the analyst should use Provider Activity Goal to identify the HCP/account's association to the plan period, and then query the related Provider Activity Goal Measure records to retrieve the specific target values, such as total interaction target, channel target, product target, or other measurable plan goals depending on configuration.
Option A is incorrect because Assessment Task and Assessment Indicator are used for assessment-style workflows, not for storing provider activity-plan target measures. They may capture structured assessment responses, but they do not represent activity-plan goal targets. Option C is incorrect because while Activity Plan is the high-level planning object, it is not the direct account-to-plan parent association described in the question, and "Account Goal" is not the specific Life Sciences child object used for provider activity target measures. Therefore, the correct parent-child pairing is Provider Activity Goal and Provider Activity Goal Measure.
=========


NEW QUESTION # 44
Choose 1 option.
A field sales rep attempts to add Immunexis to the Product Detailing section during a visit, but the product does not appear in the search results. The product record exists in Salesforce. The product must be explicitly enabled for use in visit discussions.
What should be configured in the Visit Administration tile on the Agentforce Life Sciences for Customer Engagement Admin Console?

  • A. Territory Product Alignment Rules
  • B. Product Discussion Settings
  • C. Visit Record Type Mappings

Answer: B

Explanation:
The correct answer is B because the product must be enabled for discussion in the visit-detailing experience. Salesforce's Life Sciences Visit Management developer documentation states that information entered in a provider visit typically includes product details, product messages, presentations, marketing items, and samples. Salesforce Trailhead also explains that Life Sciences Cloud uses product administration and product-message configuration to ensure reps only promote and discuss therapies within approved guardrails.
The scenario says the product exists in Salesforce, but it does not appear when the rep tries to add it to the Product Detailing section during a visit. That means the issue is not product creation; it is visit-discussion eligibility. The consultant should configure Product Discussion Settings in the Visit Administration area so Immunexis is available for product detailing and visit discussions.
Option A is incorrect because Territory Product Alignment Rules determine which products are aligned to territories, but the question specifically says the product must be explicitly enabled for use in visit discussions. Territory alignment alone does not guarantee the product appears in the Product Detailing search. Option C is also incorrect because Visit Record Type Mappings control record-type behavior, not whether a product can be discussed. Therefore, the correct configuration is Product Discussion Settings.


NEW QUESTION # 45
Choose 1 option.
At Cumulus Pharma, field sales reps report that the Next Best Action component is not visible on the account profile, even though the recommendation data is confirmed to be loaded and synced to mobile.
What is the cause of this issue?

  • A. The Life Sciences Next Best Action strategy has not been activated, so recommendations cannot be rendered on the page.
  • B. The user profile does not have permission to view the Next Best Action recommendation data.
  • C. The page layout uses the Einstein Next Best Action component instead of the Life Sciences Next Best Action component.

Answer: C

Explanation:
Option B is correct because Life Sciences Cloud for Customer Engagement uses Life Sciences-specific Next Best components for the mobile and account-profile experience. Salesforce's Life Sciences Next Best documentation explains that Next Best Action suggests timely actions such as visits and emails, and the Life Sciences Customer Engagement data model includes Life Sciences-specific recommendation objects such as Territory Account Recommended Action, Territory Account Product Message Score, and Territory Account Score. These are not the same as the generic Einstein Next Best Action component and strategy experience.
The question states that the recommendation data is already loaded and synced to mobile. That removes the most likely data-load or synchronization issue. If the data exists but the component is not visible on the account profile, the issue is most likely the wrong component placement. The page must use the Life Sciences Next Best Action component that is designed to render Life Sciences recommendations in the Life Sciences mobile app.
Option A is not the best answer because inactive strategy logic would generally prevent recommendations from being generated or returned, but the scenario confirms the recommendation data is present. Option C is also less likely because a permission problem would typically prevent access to the recommendation records or data, not specifically indicate that the component itself was configured incorrectly. Therefore, the consultant should replace the generic Einstein Next Best Action component with the Life Sciences Next Best Action component.
=========


NEW QUESTION # 46
Choose 1 option.
Cumulus Pharma completed a major territory realignment for the new fiscal year. Its sales operations team wants to ensure two things happen:
All territory-based visit metrics are recalculated.
Field sales reps in newly assigned territories gain access to historical visit data for new accounts.
Which sequence of actions should be configured in the Agentforce Life Sciences for Customer Engagement Admin Console?

  • A. Run the "Update Provider Account Territory Information" job, then run the "Visit Share Management" job.
  • B. Schedule the "Visit Share Management" job, which automatically executes the "Update Provider Account Territory Information" job when necessary.
  • C. Run the "Visit Share Management" job, then run the "Update Provider Account Territory Information" job.

Answer: A

Explanation:
Option B is correct because the two requirements depend on two different territory-related maintenance jobs, and the territory information should be refreshed before historical visit sharing is recalculated. Salesforce's Life Sciences Cloud documentation describes Provider Account Territory Information as engagement data between an account and a user within an assigned territory, including visit-related information such as next provider visit date and preferred address. After a major territory realignment, this data must be updated first so that territory-based account and visit metrics reflect the new alignments.
After that, the Visit Share Management job should be run. Salesforce Help states that, to share historical account visit records after territory realignments, admins run the Visit Share Management job so field users continue to have access to relevant historical visit data. That exactly matches the second requirement in the question: newly assigned reps must gain access to historical visit data for accounts that now belong to their territories.
Option A is incorrect because the question asks for the correct sequence, and Salesforce documentation does not indicate that Visit Share Management should be relied on to automatically execute the territory information update job. Option C is incorrect because running visit sharing before updating provider-account-territory information can share records based on stale territory data. Therefore, the correct operational sequence is: update Provider Account Territory Information first, then run Visit Share Management.
=========


NEW QUESTION # 47
Choose 1 option.
Cumulus Pharma discovered a gap in the current call-detailing process. While field sales reps are successfully capturing consent for the "Immunexis KOL Webinar Series," some records are submitted without a digital signature. To satisfy strict audit requirements, the company mandates that every consent captured on a mobile device must include a captured signature from the Healthcare Provider (HCP). This requirement must be enforced globally within the Agentforce Life Sciences mobile app, ensuring the signature pad is mandatory during the consent flow.
Which step in the Admin Console should the Agentforce Life Sciences Consultant configure?

  • A. Navigate to Consent Administration, locate the Signature Section, and change the configuration setting to Required.
  • B. Create a validation rule on the Communication Subscription Consent object to ensure the DigitalSignatureId field is not null.
  • C. Assign the Agentforce Enforce Electronic Signature custom permission to the field sales rep profile.

Answer: A

Explanation:
The correct answer is B because this is a global mobile consent-capture behavior that should be configured in Consent Administration, not enforced through a custom validation rule or permission workaround. Salesforce Life Sciences Consent Management is used to capture, manage, and track HCP consent for communication channels and subscription preferences. Salesforce's setup guidance for Consent Management directs administrators to the Life Sciences Commercial app, then Admin Console, and then Consent setup areas, which is where consent behavior is configured for the Customer Engagement experience.
The scenario requires that every consent captured on a mobile device include an HCP signature. The appropriate admin configuration is to locate the Signature Section in Consent Administration and set it to Required. This makes the signature pad mandatory during the consent flow and ensures reps cannot submit consent records without capturing the required signature.
Option A is not the best answer because a validation rule on Communication Subscription Consent may block saves after the user attempts submission, but it does not configure the guided mobile consent experience or make the signature pad properly required in the flow. Option C is also incorrect because a custom permission would control access or behavior by profile, but the requirement is global enforcement in the mobile consent flow. Therefore, the consultant should configure the Signature Section as Required in Consent Administration.
=========


NEW QUESTION # 48
Choose 1 option.
Cumulus Pharma wants to ensure that whenever a field sales rep discusses a product during a visit, for example "Immunexis," the rep is required to record product-specific information before being allowed to submit the visit.
How should the Agentforce Life Sciences Consultant configure this requirement?

  • A. Create a validation rule on the Visit object that checks for discussions on the "Immunexis" product.
  • B. Mark the Comments field as required on the Provider Visit Product Discussion page layout.
  • C. Enable Require Discussion in Product Discussion Settings for the "Immunexis" product record.

Answer: C

Explanation:
Option C is correct because the requirement is product-specific and should be configured through Product Discussion Settings, not through a generic page-layout or Visit validation rule. Salesforce's Life Sciences Cloud Visit Management data model includes Provider Visit Product Discussion as the object that represents products discussed during a visit, including key details about the product brand, therapeutic area, and related information. Salesforce also documents ProviderVisitProdDiscussion as representing additional notes or information about products discussed during a healthcare provider visit.
The question asks for a configuration that applies when a specific product, such as Immunexis, is discussed. Enabling Require Discussion in Product Discussion Settings for the product record is the most targeted standard configuration because it ties the requirement to that product's visit discussion behavior.
Option A is not the best answer because a custom validation rule on Visit would have to inspect related product-discussion records and could become complex or unreliable for mobile visit submission behavior. Option B is also insufficient because making a Comments field required on the page layout would apply based on the layout, not specifically when Immunexis is discussed. It also would not necessarily enforce product-specific discussion requirements across all relevant visit submission paths. Therefore, the consultant should enable Require Discussion in Product Discussion Settings for the Immunexis product record.
=========


NEW QUESTION # 49
Choose 1 option.
Cumulus Pharma uses a geographic territory model where "Bay Area General Hospital" is aligned to the "San Francisco North" territory based on zip code. A Healthcare Provider (HCP), whose primary office address is located in Beverly Hills, falls under the "Los Angeles South" territory. However, this HCP also actively treats patients at Bay Area General Hospital. The HCP should be automatically aligned to the "San Francisco North" territory as well, ensuring the local field sales rep can manage the relationship based on the HCP's work at the hospital.
Which configuration in the Agentforce Life Sciences Admin Console meets this requirement?

  • A. Create an account assignment rule in Territory Management to inherit the territory from the Parent Account field.
  • B. Create a territory geo assignment rule using the zip code of the hospital and apply it to the HCP's record.
  • C. Create an affiliation alignment rule specifying the Territory and the Affiliation Role, for example, "Affiliated Practice."

Answer: C

Explanation:
The correct answer is C because the HCP should be aligned to the San Francisco North territory based on an affiliation relationship with Bay Area General Hospital, not based on the HCP's primary address. Salesforce Life Sciences Cloud documentation explains that affiliation alignment rules are used to automatically align affiliated accounts to specific territories, and that rules can be created based on criteria such as account type and affiliation details. Salesforce also describes territory alignment for affiliated accounts as a way to determine which accounts users can view and manage based on affiliation-based territory logic.
In this scenario, the hospital is already aligned to San Francisco North through geography. The HCP's personal primary address places them in Los Angeles South, but their active work relationship with Bay Area General Hospital means they should also be aligned to San Francisco North. An affiliation alignment rule can evaluate that relationship and the relevant Affiliation Role, such as "Affiliated Practice," so the HCP is automatically aligned to the hospital-based territory.
Option A is incorrect because a geo assignment rule using the hospital zip code would not apply correctly to an HCP whose primary address is in Beverly Hills. Option B is incorrect because the relationship is not described as a parent-account hierarchy; it is an affiliation. Therefore, the correct configuration is an affiliation alignment rule with the appropriate territory and affiliation role.


NEW QUESTION # 50
Choose 1 option.
A field sales rep attempts to start a remote engagement session but receives an error indicating that they do not have permission to access the video service credentials. The rep's profile is verified in the Life Sciences Field Sales Representative permission set.
Which additional permission should an Agentforce Life Sciences Consultant assign?

  • A. Grant External Credential Principal Access permission.
  • B. Add the rep to the Twilio Users Public Group.
  • C. Provide the rep with the Auth Token for first-time authentication.

Answer: A

Explanation:
Option A is correct because Remote Engagement with Twilio uses Salesforce named and external credentials, and users need access to the external credential principal to use those credentials. Salesforce Help for configuring Twilio credentials in Life Sciences Remote Engagement states that the Life Sciences Customer Engagement managed package includes the named and external credentials for Twilio. The same Salesforce Help result specifically references selecting External Credential Principal Access as part of the setup. This aligns directly with the error: the field sales rep cannot access the video service credentials, even though the Life Sciences Field Sales Representative permission set has been verified.
Option B is incorrect because the solution is not to manually provide the rep with a Twilio authentication token. That approach would be insecure and inconsistent with Salesforce's named/external credential model. Credentials should be managed centrally through Salesforce configuration, not distributed directly to end users. Option C is also incorrect because "Twilio Users Public Group" is not the documented permission mechanism for accessing the video service credentials in Life Sciences Cloud Remote Engagement.
Salesforce's broader named credential security documentation also explains that external credential principals can be mapped to permission sets and profiles so users can make callouts to external systems with the right access. That supports the need to grant External Credential Principal Access rather than changing the rep's profile or sharing tokens manually.
=========


NEW QUESTION # 51
Choose 1 option.
Cumulus Pharma requires the Agentforce Life Sciences for Customer Engagement Account Summary to include historical data from the Account record and related Healthcare Provider and Contact Point Address records.
Which configuration defines the object relationships for this summary?

  • A. Actionable Relationship Center
  • B. Cross-Object Field History Graph
  • C. Affiliation Alignment Rules

Answer: B

Explanation:
Option A is correct because Account Summarization uses a cross-object graph to define which objects and relationships are included in the generated summary. Salesforce Help states that administrators can create cross-object graphs from a predefined Account Summarization template to provide a complete view of an account and its related objects. This directly matches the requirement to include Account data and related Healthcare Provider and Contact Point Address information in the summary.
The phrase "historical data" is also important. Salesforce Account Summarization setup includes configuring history tracking for the fields included in the template, so Agentforce can summarize recent changes from the selected objects and fields. The cross-object graph defines the relationship structure, while field history tracking provides the change history used in the summary.
Option B, Actionable Relationship Center, is not the best answer. Actionable Relationship Center is used to visualize related records and relationships, but the Account Summary configuration specifically relies on cross-object graphs. Option C, Affiliation Alignment Rules, is unrelated because those rules support territory alignment for affiliated accounts, not Account Summary object relationships. Therefore, the consultant should use a Cross-Object Field History Graph to define the Account, Healthcare Provider, Contact Point Address, and related-object structure used by Agentforce Account Summary.
=========


NEW QUESTION # 52
Choose 1 option.
Cumulus Pharma wants field sales reps to see the most relevant account information directly in the aligned account list.
How should the Agentforce Life Sciences Consultant configure the account list columns after a new account list is created?

  • A. Set the list type to Default and configure up to four fields as visible columns.
  • B. Configure the Search list to display up to five account fields as columns in search results.
  • C. Assign ownership to field sales reps and ensure they can configure visible columns.

Answer: A

Explanation:
The correct answer is C because aligned account lists in Agentforce Life Sciences for Customer Engagement are configured through account list settings, where the consultant defines how the list appears to users in the mobile experience. Salesforce describes account management features in Life Sciences Cloud as enabling users to organize, prioritize, and focus on accounts through lists and filters in the Customer Engagement app. The account list configuration controls which fields appear to reps so they can quickly understand account context without opening every account record.
In this scenario, the business wants field sales reps to see the most relevant account information directly in the aligned account list. After creating the account list, the consultant should configure it as the Default list type and select up to four visible fields as columns. This gives reps a concise, mobile-friendly view of the most important account details.
Option A is incorrect because configuring the Search list affects search-result display behavior, not the aligned account list columns. It also refers to up to five account fields, which does not match the aligned account list column configuration described in the question. Option B is incorrect because assigning ownership to field sales reps does not define the visible columns in the list. Column configuration is an admin setup activity, not something resolved by record ownership. Therefore, the consultant should set the list type to Default and configure up to four visible fields.
=========


NEW QUESTION # 53
Choose 1 option.
Cumulus Pharma uses standard Salesforce dashboards to help field sales reps track basic activities, such as visits and engagement trends. After customizing a dashboard and adding it to the home page, the reps report that funnel charts are not visible when viewing the dashboard in the Agentforce Life Sciences mobile app, even though they appear on desktop.
What should an Agentforce Life Sciences Consultant recommend?

  • A. The underlying data is not available for the selected reporting period.
  • B. Mobile-specific dashboard filters are required for mobile devices.
  • C. Funnel charts are not supported in the mobile app.

Answer: C

Explanation:
Option A is correct because this is a mobile rendering limitation, not a data or filter issue. Salesforce documentation for reports and dashboards on mobile describes differences and limitations between desktop and the Salesforce mobile app. When a dashboard component appears on desktop but not in the mobile app, the consultant should first check mobile dashboard support and component compatibility rather than assuming that the report data is missing.
The question states that the funnel charts appear on desktop, which strongly indicates that the underlying reports and reporting periods are valid. If the data were missing for the selected reporting period, the chart would fail or show no data consistently, not only on mobile. Option C is therefore not a good fit. Option B is also incorrect because dashboard filters can affect what data is shown, but they do not make an unsupported chart type render in the mobile app.
Salesforce Help also discusses making dashboards available in mobile workflows and notes that mobile dashboard behavior depends on how dashboards are embedded and rendered in the Salesforce mobile app. For this scenario, the consultant should recommend replacing the funnel chart with a mobile-supported visualization or providing an alternate dashboard component for mobile users. Therefore, the correct answer is that funnel charts are not supported in the mobile app.


NEW QUESTION # 54
Choose 1 option.
Cumulus Pharma is implementing a feature where Healthcare Providers (HCPs) sign for drug samples on an iPad. The company's compliance team states that, to meet Food and Drug Administration (FDA) 21 CFR Part 11 requirements, a simple image of the signature is insufficient; the system must link the signature to the data and the user's credentials at the exact moment of signing.
Which feature generates this tamper-evident audit trail?

  • A. Digital Verification
  • B. Field Audit Trail
  • C. Adobe Sign

Answer: A

Explanation:
Digital Verification is the correct answer because Salesforce Life Sciences resources describe it as the native capability used to manage electronic signatures in Salesforce and support an organization's 21 CFR Part 11 compliance requirements. Salesforce Help states that Electronic Signatures can be set up using the Digital Verifications feature, allowing signatures to be managed in Salesforce instead of relying on a third-party application. It also references creating a "signature trail," which is the key concept in this question: the signature is not just a stored image, but part of a controlled verification process tied to the signed record and signer context.
Field Audit Trail is not the best answer because it tracks field history and retention for data changes; it does not provide the electronic-signature process required for HCP sample acknowledgments. Adobe Sign is also not the best answer because the question asks for the Salesforce Life Sciences feature that generates the audit trail inside the Life Sciences process. The Salesforce Developer Guide also identifies Digital Verification standard objects as part of the electronic-signature data model, reinforcing that Digital Verification is the Life Sciences capability designed for this use case.


NEW QUESTION # 55
Choose 1 option.
Cumulus Pharma wants to launch a new product, "Immunexis," and mandates that field sales reps must capture explicit opt-in consent from Healthcare Providers (HCPs) before sending any digital marketing materials. The following records are already configured in Agentforce Life Sciences:
Data Use Purpose record for "Immunexis Marketing"
Communication Subscription record named "Immunexis KOL Webinar Series"
Engagement Channel Type record for "Email"
When reps attempt to capture consent on their iPads, they can see the "Immunexis KOL Webinar Series" subscription, but they cannot select "Email" as a channel to capture the opt-in preference.
Which step resolves this issue so the rep can select "Email" for this subscription?

  • A. Navigate to the Consent Administration tab in the Admin Console and check the box for "Allow Email Channel."
  • B. Create a Communication Subscription Channel Type junction record to link the Subscription to the Engagement Channel Type.
  • C. Create a Communication Subscription Consent record for the user profile to activate the channel visibility.

Answer: B

Explanation:
Option B is correct because Communication Subscription Channel Type is the junction record that links a Communication Subscription to an Engagement Channel Type. Salesforce's Life Sciences Consent Management data model includes Communication Subscription, Communication Subscription Channel Type, Communication Subscription Consent, Data Use Purpose, Engagement Channel Type, and related consent objects. This confirms that subscription-channel availability is modeled through Communication Subscription Channel Type, not only through the subscription or channel records separately.
Salesforce's Communication Subscription objects documentation states that Communication Subscription Channel Type specifies the engagement channel that can be used to contact the customer for a communication subscription. The Salesforce object reference also identifies fields on Communication Subscription Channel Type such as EngagementChannelTypeId, confirming that this object connects the subscription to the channel.
Option A is incorrect because there is no indication that a generic "Allow Email Channel" checkbox controls this relationship. Option C is also incorrect because Communication Subscription Consent stores an individual HCP's consent preference after the channel-subscription combination exists. It does not make the Email channel selectable for the subscription. Therefore, the consultant must create a Communication Subscription Channel Type record linking "Immunexis KOL Webinar Series" to the Email Engagement Channel Type.


NEW QUESTION # 56
......

ALS-Con-201 Exam Dumps Pass with Updated 2026: https://www.braindumpspass.com/Salesforce/ALS-Con-201-practice-exam-dumps.html

Free ALS-Con-201 Exam Dumps to Pass Exam Easily: https://drive.google.com/open?id=1OBWUa_WOYeoyqeeJTqIVqqGtW5D_Dg8A

Related Articles

more
Salesforce ALS-Con-201 Certification Practice Exam